X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
index medicus (41) 41
male (30) 30
female (24) 24
adult (21) 21
middle aged (17) 17
aged (10) 10
genetics & heredity (10) 10
pharmacology & pharmacy (8) 8
phenotype (8) 8
methotrexate (7) 7
rheumatoid arthritis (7) 7
child (6) 6
diagnosis (6) 6
genetic aspects (6) 6
adolescent (5) 5
biology (5) 5
child, preschool (5) 5
coronary-artery-disease (5) 5
deletions (5) 5
genotype (5) 5
magnetic resonance imaging (5) 5
polymerase chain reaction (5) 5
radiology, nuclear medicine & medical imaging (5) 5
rheumatology (5) 5
risk factors (5) 5
serbia (5) 5
aged, 80 and over (4) 4
arthritis, rheumatoid - genetics (4) 4
biochemistry & molecular biology (4) 4
cancer (4) 4
disease (4) 4
exercise test (4) 4
expression (4) 4
gene frequency (4) 4
gene mutations (4) 4
genes (4) 4
genetic predisposition to disease (4) 4
homozygote (4) 4
medicine (4) 4
medicine, research & experimental (4) 4
modifying antirheumatic drugs (4) 4
mutation (4) 4
oncology (4) 4
pharmacogenetics (4) 4
polymorphism, genetic (4) 4
pregnancy (4) 4
research (4) 4
risk-factors (4) 4
sensitivity and specificity (4) 4
tumor proteins (4) 4
american-heart-association (3) 3
analysis (3) 3
arthritis, rheumatoid - diagnosis (3) 3
arthritis, rheumatoid - drug therapy (3) 3
arthritis, rheumatoid - enzymology (3) 3
association (3) 3
biomedicine (3) 3
biotechnology & applied microbiology (3) 3
cardiac & cardiovascular systems (3) 3
case-control studies (3) 3
cytomegalovirus - isolation & purification (3) 3
diagnosis, differential (3) 3
electrocardiography (3) 3
exercise (3) 3
genetic polymorphism (3) 3
genetic research (3) 3
health aspects (3) 3
heart (3) 3
immunohistochemistry (3) 3
immunophenotype (3) 3
infant (3) 3
locus (3) 3
lung neoplasms - genetics (3) 3
medicine, general & internal (3) 3
methotrexate - adverse effects (3) 3
mri (3) 3
pediatrics (3) 3
polymorphism (3) 3
prognosis (3) 3
prospective studies (3) 3
reduced folate carrier (3) 3
severity of illness index (3) 3
toxicity (3) 3
tumor suppressor protein p53 - genetics (3) 3
variants (3) 3
acute lymphoblastic-leukemia (2) 2
age (2) 2
agronomy (2) 2
aids (2) 2
aml (2) 2
amplification (2) 2
analysis of variance (2) 2
antirheumatic agents - adverse effects (2) 2
antiviral agents - therapeutic use (2) 2
article (2) 2
atherosclerosis (2) 2
base sequence (2) 2
biomedicine general (2) 2
blood-flow (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genetika, ISSN 0534-0012, 2016, Volume 48, Issue 2, pp. 707 - 716
Retinopathy of prematurity (ROP) is a vascular proliferative disorder of retina, that causes visual impairment in premature children. Beside well known risk... 
4a/b polymorphism | Retinopathy of prematurity | SNP | T-786C polymorphism | ENOS gene | AGRONOMY | RISK-FACTORS | ANGIOGENESIS | VARIANTS | retinopathy of prematurity | eNOS gene | INFANTS | GENETICS & HEREDITY | GROWTH-FACTOR | BIRTH | ASSOCIATION
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 3/2013, Volume 69, Issue 3, pp. 377 - 383
Gamma-glutamyl hydrolase (GGH), cyclin D1 (CCND1) and thymidylate synthase (TS) genes encode enzymes that are involved in methotrexate (MTX) action. In a group... 
Biomedicine | Pharmacology/Toxicology | Methotrexate | Rheumatoid arthritis | Genetic polymorphism | MODIFYING ANTIRHEUMATIC DRUGS | REDUCED FOLATE CARRIER | G870A POLYMORPHISM | COMMON POLYMORPHISMS | RHEUMATOID-ARTHRITIS PATIENTS | ACUTE LYMPHOBLASTIC-LEUKEMIA | CANCER SUSCEPTIBILITY | FUNCTIONAL-ANALYSIS | PHARMACOLOGY & PHARMACY | REDUCTASE GENES | THYMIDYLATE-SYNTHASE | Bone Marrow Diseases - enzymology | Multivariate Analysis | Humans | Methotrexate - pharmacokinetics | Middle Aged | gamma-Glutamyl Hydrolase - metabolism | Male | Young Adult | Arthritis, Rheumatoid - drug therapy | Aged, 80 and over | Antirheumatic Agents - adverse effects | Adult | Female | Odds Ratio | gamma-Glutamyl Hydrolase - genetics | Arthritis, Rheumatoid - diagnosis | Bone Marrow - drug effects | Severity of Illness Index | Genetic Predisposition to Disease | Pharmacogenetics | Bone Marrow Diseases - chemically induced | Gene Frequency | Risk Factors | Thymidylate Synthase - metabolism | Arthritis, Rheumatoid - enzymology | Logistic Models | Chi-Square Distribution | Thymidylate Synthase - genetics | Bone Marrow Diseases - genetics | Polymorphism, Genetic | Methotrexate - adverse effects | Arthritis, Rheumatoid - genetics | Phenotype | Analysis of Variance | Cyclin D1 - genetics | Antirheumatic Agents - pharmacokinetics | Aged | Rheumatoid factor | Complications and side effects | Enzymes | Genes | Hydrolases | Genetic aspects | Universities and colleges | Bone marrow | Genotype & phenotype | Drug therapy | Toxicity | Patients | Index Medicus
Journal Article
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, ISSN 1482-1826, 04/2019, Volume 22, Issue 1, pp. 142 - 149
Purpose: Treatment of Ischemic stroke (IS) in acute phase is based on the use of thrombolytic rt-PA therapy. We aimed to determine whether different alleles... 
SYSTEMATIC ANALYSIS | GLOBAL BURDEN | HEART | RISK-FACTORS | PLASMINOGEN-ACTIVATOR | GENOTYPE | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | 4G/5G POLYMORPHISM | ANGIOTENSIN-CONVERTING ENZYME | HEALTH-CARE PROFESSIONALS
Journal Article
ANNALS OF THE RHEUMATIC DISEASES, ISSN 0003-4967, 06/2019, Volume 78, pp. 1533 - 1533
Conference Proceeding
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 03/2019, Volume 15, Issue 3, pp. 253 - 257
Background: Methotrexate (MTX), a folate analogue, is the most commonly used disease-modifying drug in the treatment of rheumatoid arthritis (RA). However,... 
DHFR | toxicity | methotrexate | genetic polymorphism | rheumatoid arthritis | pharmacogenetics | EFFICACY | GENOTYPE | BIOCHEMISTRY & MOLECULAR BIOLOGY | POOR RESPONSE | DISEASE | RESISTANCE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Index Medicus
Journal Article
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, ISSN 0040-8727, 04/2019, Volume 247, Issue 4, pp. 259 - 264
Early-onset neonatal sepsis (EOS) is diagnosed during the first 7 days of neonatal life and is the major cause of morbidity and mortality among preterm... 
C-REACTIVE PROTEIN | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | INFECTIONS | preterm infants | SUSCEPTIBILITY | PROCALCITONIN | gene polymorphism | INTERLEUKIN-6 | interleukin 6 | MEDICINE, GENERAL & INTERNAL | BIRTH-WEIGHT INFANTS | tumor necrosis factor alpha | SEPTIC SHOCK | early onset sepsis | EXPRESSION
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 2012, Volume 30, Issue 2, pp. 178 - 183
Journal Article
EUROPEAN JOURNAL OF MEDICAL RESEARCH, ISSN 0949-2321, 10/2009, Volume 14, pp. 91 - 91
Conference Proceeding
Journal Article
International Journal of Oral & Maxillofacial Surgery, ISSN 0901-5027, 2010, Volume 39, Issue 9, pp. 909 - 915
Journal Article
Journal Article
Journal Article
GENETIKA-BELGRADE, ISSN 0534-0012, 2016, Volume 48, Issue 1, pp. 395 - 408
A folate analogue methotrexate (MTX) is the most commonly used disease -modifying drug in the treatment of rheumatoid arthritis. However, the clinical response... 
MODIFYING ANTIRHEUMATIC DRUGS | AGRONOMY | RFC1 | REDUCED FOLATE CARRIER | methotrexate | MTHFR | COMMON MUTATION | rheumatoid arthritis | DISEASE-ACTIVITY | MTHFD1 | RISK-FACTOR | C677T POLYMORPHISM | GENETICS & HEREDITY | METHYLENETETRAHYDROFOLATE REDUCTASE GENE | genetic polymorphism | SINGLE-NUCLEOTIDE POLYMORPHISMS | THYMIDYLATE-SYNTHASE | ADVERSE EVENTS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.